Please login to the form below

Not currently logged in

GSK appoints new chief financial officer

GSK has announced that Julian Heslop will retire as chief financial officer at the end of March 2011 and will be replaced by Simon Dingemans
GlaxoSmithKline (GSK) has announced that Julian Heslop will retire from his role as chief financial officer (CFO) and executive director at the end of March 2011. He will be replaced by Simon Dingemans who will take up the roles of chief financial officer designate and executive director with effect from January 2011.

Simon Dingemans, new CFO at GSK

Simon Dingemans

Dingemans will join GSK from investment bank Goldman Sachs. During his 25 year career in investment banking, Dingemans has worked across multiple sectors including pharmaceuticals and consumer healthcare. Recently, he worked with GSK on their joint project with Pfizer to establish specialist HIV company ViiV Healthcare.

GSK CEO, Andrew Witty, said: "In joining our executive team, Simon will bring valuable experience and capability to support us in our strategy to grow and diversify GSK's business through organic means and bolt-on acquisitions. He will also be responsible for delivering cost savings from our global restructuring programme and implementing further measures to simplify our operational model. I am delighted that someone of his calibre will be joining GSK."

9th September 2010


Featured jobs

Subscribe to our email news alerts


Add my company

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...